You’re offline. This is a read only version of the page.
MassBio
Massachusetts Biotechnology Council
Primary Menu
Search for:
Search
Open search form
Sign In/Create Account
Pay Company Dues
Become a Member
Search for:
Search
Resources
MassBio
Hub
– Conference Center
Member Directory
COVID-19 Resource Center
Innovation Services
Policy & Advocacy
Economic Development
Industry Snapshot
Career Center
Pay Company Dues
Events
State of Partnering 2021
Events Calendar
Overview of Events
Get Involved
MassBio Edge
MassBio
Edge
Preferred Partners
Employee Rewards
Edge
Benefits
Initiatives
State of Possible 2025 Report
Virtual Member Benefits
Emergency SupplyHub
Equity, Diversity, and Inclusion
Open Letter 2.0 – CEO Pledge for ED&I
Value of Health
Digital Health
BioReady Communities
About Us
About Us
Benefits of Membership
Become a Member
Sponsorship Opportunities
Staff
Board of Directors
MassBioEd
FAQs
Contact Us
News
News & Thought Leadership
State of Possible Podcast
Sign In/Create Account
Pay Company Dues
Become a Member
Open search form
Digital Health Innovations in the Post-COVID Drug Development Paradigm
30
minutes
What is the future paradigm of modern drug development and how will digital health companies drive new innovations?
What is the future paradigm of modern drug development and how will digital health companies drive new innovations?
Speakers
Adam Landman
-
VP, Chief Information & Digital Innovation Officer, BWH
Claire Bonaci
-
Director, Business Development, US Health & Life Sciences, Microsoft
Craig Lipset
-
Advisor & Founder at Clinical Innovation Partners, Former Head of Clinical Innovation, Pfizer
